Neglected Tropical Diseases Diagnosis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025

Description

Persistence Market Research has recently released a comprehensive report on the global Neglected Tropical Diseases Diagnosis Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

Neglected Tropical Diseases Diagnosis Market Size (2025E): US$ 7,600.0 Mn
Projected Market Value (2032F): US$ 10,204.8 Mn
Global Market Growth Rate (CAGR 2025 to 2032): 4.3%

Neglected Tropical Diseases Diagnosis Market - Report Scope:

The neglected tropical diseases diagnosis market covers diagnostic solutions used to detect a variety of tropical diseases that predominantly affect low-income populations in tropical and subtropical regions. These diseases include dengue, leprosy, Chagas disease, lymphatic filariasis, and many others. Diagnostic methods range from conventional to molecular and modern technologies. Increasing awareness, government initiatives, and technological advancements in diagnostic tools are shaping the market. The rising prevalence of neglected tropical diseases and expanding healthcare infrastructure in emerging economies are key factors driving market expansion.

Market Growth Drivers:

The neglected tropical diseases diagnosis market is propelled by multiple factors. Primarily, the growing prevalence and resurgence of tropical diseases in endemic regions necessitate early and accurate diagnosis, driving demand for advanced diagnostic technologies. Increased funding and support from global health organizations and governments to combat neglected tropical diseases have resulted in expanded screening and diagnostic programs. Innovations in molecular diagnostics and point-of-care testing are improving disease detection accuracy and accessibility, particularly in resource-limited settings. Moreover, expanding healthcare infrastructure in developing countries and heightened public health awareness are further bolstering market growth.

Market Restraints:

Despite significant growth prospects, the market faces certain challenges. Limited healthcare infrastructure and insufficient diagnostic facilities in rural and remote areas restrict market penetration. High costs associated with modern diagnostic tools can impede adoption, especially in low-income regions. Furthermore, lack of trained healthcare professionals and logistical challenges in deploying diagnostic solutions in endemic zones pose barriers. Inconsistent disease reporting and underdiagnosis due to stigma or lack of awareness also affect accurate market assessments and slow intervention efforts.

Market Opportunities:

The neglected tropical diseases diagnosis market offers promising opportunities driven by technological advancements and increasing investments. The development of rapid, low-cost, and user-friendly point-of-care diagnostic devices presents new avenues for expanding market reach, especially in underserved areas. Collaborative initiatives among governments, NGOs, and private companies aiming to eliminate neglected tropical diseases provide strong growth potential. Expanding research focused on molecular diagnostics and multiplex testing to simultaneously detect multiple diseases can revolutionize screening programs. Additionally, growing focus on personalized medicine and integration of AI and digital health tools into diagnostics are set to create lucrative opportunities.

Key Questions Answered in the Report:

What are the primary factors driving the global neglected tropical diseases diagnosis market's growth?
Which regions and disease segments are experiencing the highest demand for diagnostic solutions?
How are innovations in diagnostic technologies influencing market dynamics?
Who are the key players in the neglected tropical diseases diagnosis market, and what strategies are they adopting to stay competitive?
What are the emerging trends and future projections for the global neglected tropical diseases diagnosis market?

Competitive Intelligence and Business Strategy:

Leading companies in the global neglected tropical diseases diagnosis market, such as F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Genome Diagnostics Pvt. Ltd., and others, are heavily investing in R&D to develop rapid and accurate diagnostic solutions. These companies are focusing on expanding their product portfolios, forming strategic partnerships with governments and health organizations, and strengthening their distribution networks in endemic regions. Emphasis on cost-effective, portable, and easy-to-use diagnostic tools helps them cater to the needs of resource-limited settings, thereby enhancing market presence and customer trust.

Companies Covered in This Report:

F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Abbott Laboratories
Genome Diagnostics Pvt. Ltd.
InBios International, Inc.
ZeptoMetrix
Oscar Medicare Pvt Ltd.
Coris BioConcept
Omega Diagnostics Group PLC
DiaSys Diagnostic Systems GmbH
Others

Market Segmentation

By Disease

Dengue
Rabies
Yaws
Chikungunya
Leprosy
Lymphatic Filariasis
Buruli Ulcer
Echinococcosis
Taeniasis/Cysticercosis
Dracunculiasis
Foodborne Trematodiases
Chagas Disease (American Trypanosomiasis)
African Trypanosomiasis
Soil-transmitted Helminth Infections
Onchocerciasis
Scabies and Other Ectoparasites
Schistosomiasis
Snakebite Envenoming
Leishmaniasis

By Diagnostic Method

Conventional
Molecular/Modern

By Service Type

Centralized
POC

By End-use

Clinical Laboratories
Hospitals/Clinics
Home Healthcare

By Region

North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East and Africa

Product Code: PMRREP35377

1. Executive Summary

1.1. Global Neglected Tropical Diseases Diagnosis Market Snapshot, 2025-2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
2.3. Macro-economic Factors
- 2.3.1. Public Health Spending and International Aid
- 2.3.2. Global Health Policy and Regulatory Frameworks
- 2.3.3. Geopolitical Stability and Infrastructure Development
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Diagnostic Method Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. PESTLE Analysis
3.5. Porter's Five Force Analysis

4. Price Analysis, 2025A

4.1. Key Highlights
4.2. Key Factors Impacting Service Costs
4.3. Pricing Analysis, By Diagnostic Method

5. Global Neglected Tropical Diseases Diagnosis Market Outlook

5.1. Key Highlights
- 5.1.1. Market Volume (Units) Projections
- 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
5.3. Global Neglected Tropical Diseases Diagnosis Market Outlook: Disease
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Disease, 2019-2024
- 5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
  - 5.3.3.1. Dengue
  - 5.3.3.2. Rabies
  - 5.3.3.3. Yaws
  - 5.3.3.4. Chikungunya
  - 5.3.3.5. Leprosy
  - 5.3.3.6. Lymphatic Filariasis
  - 5.3.3.7. Buruli Ulcer
  - 5.3.3.8. Echinococcosis
  - 5.3.3.9. Taeniasis/Cysticercosis
  - 5.3.3.10. Dracunculiasis
  - 5.3.3.11. Foodborne Trematodiases
  - 5.3.3.12. Chagas Disease (American Trypanosomiasis)
  - 5.3.3.13. African Trypanosomiasis
  - 5.3.3.14. Soil-transmitted Helminth Infections
  - 5.3.3.15. Onchocerciasis
  - 5.3.3.16. Scabies and Other Ectoparasites
  - 5.3.3.17. Schistosomiasis
  - 5.3.3.18. Snakebite Envenoming
  - 5.3.3.19. Leishmaniasis
- 5.3.4. Market Attractiveness Analysis: Disease
5.4. Global Neglected Tropical Diseases Diagnosis Market Outlook: Diagnostic Method
- 5.4.1. Introduction / Key Findings
- 5.4.2. Historical Market Size (US$ Mn) Analysis, By Diagnostic Method, 2019-2024
- 5.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
  - 5.4.3.1. Conventional
  - 5.4.3.2. Molecular/Modern
- 5.4.4. Market Attractiveness Analysis: Diagnostic Method
5.5. Global Neglected Tropical Diseases Diagnosis Market Outlook: Service Type
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Mn) Analysis, By Service Type, 2019-2024
- 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
  - 5.5.3.1. Centralized
  - 5.5.3.2. POC
- 5.5.4. Market Attractiveness Analysis: Service Type
5.6. Global Neglected Tropical Diseases Diagnosis Market Outlook: End Use
- 5.6.1. Introduction / Key Findings
- 5.6.2. Historical Market Size (US$ Mn) Analysis, By End Use, 2019-2024
- 5.6.3. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
  - 5.6.3.1. Clinical Laboratories
  - 5.6.3.2. Hospitals/Clinics
  - 5.6.3.3. Home Healthcare
- 5.6.4. Market Attractiveness Analysis: End Use

6. Global Neglected Tropical Diseases Diagnosis Market Outlook: Region

6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
6.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region

7. North America Neglected Tropical Diseases Diagnosis Market Outlook

7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Disease
- 7.2.3. By Diagnostic Method
- 7.2.4. By Service Type
- 7.2.5. By End Use
7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
- 7.4.1. Dengue
- 7.4.2. Rabies
- 7.4.3. Yaws
- 7.4.4. Chikungunya
- 7.4.5. Leprosy
- 7.4.6. Lymphatic Filariasis
- 7.4.7. Buruli Ulcer
- 7.4.8. Echinococcosis
- 7.4.9. Taeniasis/Cysticercosis
- 7.4.10. Dracunculiasis
- 7.4.11. Foodborne Trematodiases
- 7.4.12. Chagas Disease (American Trypanosomiasis)
- 7.4.13. African Trypanosomiasis
- 7.4.14. Soil-transmitted Helminth Infections
- 7.4.15. Onchocerciasis
- 7.4.16. Scabies and Other Ectoparasites
- 7.4.17. Schistosomiasis
- 7.4.18. Snakebite Envenoming
- 7.4.19. Leishmaniasis
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
- 7.5.1. Conventional
- 7.5.2. Molecular/Modern
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
- 7.6.1. Centralized
- 7.6.2. POC
7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
- 7.7.1. Clinical Laboratories
- 7.7.2. Hospitals/Clinics
- 7.7.3. Home Healthcare
7.8. Market Attractiveness Analysis

8. Europe Neglected Tropical Diseases Diagnosis Market Outlook

8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Disease
- 8.2.3. By Diagnostic Method
- 8.2.4. By Service Type
- 8.2.5. By End Use
8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
- 8.4.1. Dengue
- 8.4.2. Rabies
- 8.4.3. Yaws
- 8.4.4. Chikungunya
- 8.4.5. Leprosy
- 8.4.6. Lymphatic Filariasis
- 8.4.7. Buruli Ulcer
- 8.4.8. Echinococcosis
- 8.4.9. Taeniasis/Cysticercosis
- 8.4.10. Dracunculiasis
- 8.4.11. Foodborne Trematodiases
- 8.4.12. Chagas Disease (American Trypanosomiasis)
- 8.4.13. African Trypanosomiasis
- 8.4.14. Soil-transmitted Helminth Infections
- 8.4.15. Onchocerciasis
- 8.4.16. Scabies and Other Ectoparasites
- 8.4.17. Schistosomiasis
- 8.4.18. Snakebite Envenoming
- 8.4.19. Leishmaniasis
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
- 8.5.1. Conventional
- 8.5.2. Molecular/Modern
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
- 8.6.1. Centralized
- 8.6.2. POC
8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
- 8.7.1. Clinical Laboratories
- 8.7.2. Hospitals/Clinics
- 8.7.3. Home Healthcare
8.8. Market Attractiveness Analysis

9. East Asia Neglected Tropical Diseases Diagnosis Market Outlook

9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Disease
- 9.2.3. By Diagnostic Method
- 9.2.4. By Service Type
- 9.2.5. By End Use
9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
- 9.4.1. Dengue
- 9.4.2. Rabies
- 9.4.3. Yaws
- 9.4.4. Chikungunya
- 9.4.5. Leprosy
- 9.4.6. Lymphatic Filariasis
- 9.4.7. Buruli Ulcer
- 9.4.8. Echinococcosis
- 9.4.9. Taeniasis/Cysticercosis
- 9.4.10. Dracunculiasis
- 9.4.11. Foodborne Trematodiases
- 9.4.12. Chagas Disease (American Trypanosomiasis)
- 9.4.13. African Trypanosomiasis
- 9.4.14. Soil-transmitted Helminth Infections
- 9.4.15. Onchocerciasis
- 9.4.16. Scabies and Other Ectoparasites
- 9.4.17. Schistosomiasis
- 9.4.18. Snakebite Envenoming
- 9.4.19. Leishmaniasis
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
- 9.5.1. Conventional
- 9.5.2. Molecular/Modern
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
- 9.6.1. Centralized
- 9.6.2. POC
9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
- 9.7.1. Clinical Laboratories
- 9.7.2. Hospitals/Clinics
- 9.7.3. Home Healthcare
9.8. Market Attractiveness Analysis

10. South Asia & Oceania Neglected Tropical Diseases Diagnosis Market Outlook

10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Disease
- 10.2.3. By Diagnostic Method
- 10.2.4. By Service Type
- 10.2.5. By End Use
10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
- 10.4.1. Dengue
- 10.4.2. Rabies
- 10.4.3. Yaws
- 10.4.4. Chikungunya
- 10.4.5. Leprosy
- 10.4.6. Lymphatic Filariasis
- 10.4.7. Buruli Ulcer
- 10.4.8. Echinococcosis
- 10.4.9. Taeniasis/Cysticercosis
- 10.4.10. Dracunculiasis
- 10.4.11. Foodborne Trematodiases
- 10.4.12. Chagas Disease (American Trypanosomiasis)
- 10.4.13. African Trypanosomiasis
- 10.4.14. Soil-transmitted Helminth Infections
- 10.4.15. Onchocerciasis
- 10.4.16. Scabies and Other Ectoparasites
- 10.4.17. Schistosomiasis
- 10.4.18. Snakebite Envenoming
- 10.4.19. Leishmaniasis
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
- 10.5.1. Conventional
- 10.5.2. Molecular/Modern
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
- 10.6.1. Centralized
- 10.6.2. POC
10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
- 10.7.1. Clinical Laboratories
- 10.7.2. Hospitals/Clinics
- 10.7.3. Home Healthcare
10.8. Market Attractiveness Analysis

11. Latin America Neglected Tropical Diseases Diagnosis Market Outlook

11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Disease
- 11.2.3. By Diagnostic Method
- 11.2.4. By Service Type
- 11.2.5. By End Use
11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
- 11.4.1. Dengue
- 11.4.2. Rabies
- 11.4.3. Yaws
- 11.4.4. Chikungunya
- 11.4.5. Leprosy
- 11.4.6. Lymphatic Filariasis
- 11.4.7. Buruli Ulcer
- 11.4.8. Echinococcosis
- 11.4.9. Taeniasis/Cysticercosis
- 11.4.10. Dracunculiasis
- 11.4.11. Foodborne Trematodiases
- 11.4.12. Chagas Disease (American Trypanosomiasis)
- 11.4.13. African Trypanosomiasis
- 11.4.14. Soil-transmitted Helminth Infections
- 11.4.15. Onchocerciasis
- 11.4.16. Scabies and Other Ectoparasites
- 11.4.17. Schistosomiasis
- 11.4.18. Snakebite Envenoming
- 11.4.19. Leishmaniasis
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
- 11.5.1. Conventional
- 11.5.2. Molecular/Modern
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
- 11.6.1. Centralized
- 11.6.2. POC
11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
- 11.7.1. Clinical Laboratories
- 11.7.2. Hospitals/Clinics
- 11.7.3. Home Healthcare
11.8. Market Attractiveness Analysis

12. Middle East & Africa Neglected Tropical Diseases Diagnosis Market Outlook

12.1. Key Highlights
12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 12.2.1. By Country
- 12.2.2. By Disease
- 12.2.3. By Diagnostic Method
- 12.2.4. By Service Type
- 12.2.5. By End Use
12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
12.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
- 12.4.1. Dengue
- 12.4.2. Rabies
- 12.4.3. Yaws
- 12.4.4. Chikungunya
- 12.4.5. Leprosy
- 12.4.6. Lymphatic Filariasis
- 12.4.7. Buruli Ulcer
- 12.4.8. Echinococcosis
- 12.4.9. Taeniasis/Cysticercosis
- 12.4.10. Dracunculiasis
- 12.4.11. Foodborne Trematodiases
- 12.4.12. Chagas Disease (American Trypanosomiasis)
- 12.4.13. African Trypanosomiasis
- 12.4.14. Soil-transmitted Helminth Infections
- 12.4.15. Onchocerciasis
- 12.4.16. Scabies and Other Ectoparasites
- 12.4.17. Schistosomiasis
- 12.4.18. Snakebite Envenoming
- 12.4.19. Leishmaniasis
12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
- 12.5.1. Conventional
- 12.5.2. Molecular/Modern
12.6. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
- 12.6.1. Centralized
- 12.6.2. POC
12.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
- 12.7.1. Clinical Laboratories
- 12.7.2. Hospitals/Clinics
- 12.7.3. Home Healthcare
12.8. Market Attractiveness Analysis

13. Competition Landscape

13.1. Market Share Analysis, 2025
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. F. Hoffmann-La Roche Ltd
  - 13.3.1.1. Overview
  - 13.3.1.2. Segments and Diseases
  - 13.3.1.3. Key Financials
  - 13.3.1.4. Market Developments
  - 13.3.1.5. Market Strategy
- 13.3.2. Thermo Fisher Scientific Inc.
- 13.3.3. Abbott Laboratories
- 13.3.4. Genome Diagnostics Pvt. Ltd.
- 13.3.5. InBios International, Inc.
- 13.3.6. ZeptoMetrix
- 13.3.7. Oscar Medicare Pvt Ltd.
- 13.3.8. Coris BioConcept
- 13.3.9. Omega Diagnostics Group PLC
- 13.3.10. DiaSys Diagnostic Systems GmbH
- 13.3.11. Others

14. Appendix

14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations

Neglected Tropical Diseases Diagnosis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032